后肾
后肾碱
嗜铬细胞瘤
医学
副神经节瘤
去甲肾上腺素
临床实习
儿茶酚胺
诊断试验
叙述性评论
泌尿系统
诊断准确性
重症监护医学
生物标志物
去甲肾上腺素
内科学
液体活检
神经内分泌肿瘤
诊断生物标志物
泌尿科
作者
Sandra Rufolo,Anna Chiara Balsamo,Francesca Parisi,Albino Coglianese,Bruno Charlier,Viviana Izzo
出处
期刊:Diagnostics
[Multidisciplinary Digital Publishing Institute]
日期:2026-04-23
卷期号:16 (9): 1263-1263
被引量:3
标识
DOI:10.3390/diagnostics16091263
摘要
Pheochromocytoma (PhC) and Paraganglioma (PG) are rare neuroendocrine tumors characterized by uncontrolled catecholamine secretion. Although rare, much attention is still devoted to identifying a unique biochemical signature of these diseases to reduce false positives, thus improving patient outcomes, and customizing clinical laboratory practices to available resources and specific diagnostic needs. Emerging knowledge into catecholamine metabolism has greatly improved diagnostic strategies, with current international guidelines recognizing plasma free or urinary fractionated metanephrine measurements as the recommended first-line biochemical tests. This narrative review highlights the clinical utility of measuring plasma free metanephrines compared to urinary catecholamines in the diagnosis of these conditions. Plasma free metanephrines offer superior sensitivity and specificity compared to catecholamines due to their continuous secretion, which is independent from tumor size and catecholamine fluctuations. This review also addresses preanalytical and methodological challenges, emphasizing patient preparation, sample stability and advanced analytical techniques currently available. Methodologies such as LC-MS/MS have demonstrated improved diagnostic accuracy compared to traditional immunoassays, offering enhanced analytical performance in terms of sensitivity, specificity, and reduced susceptibility to interferences.
科研通智能强力驱动
Strongly Powered by AbleSci AI